+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Viscosupplementation Market - Global Forecast 2026-2032- Product Image
Viscosupplementation Market - Global Forecast 2026-2032- Product Image
New

Viscosupplementation Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 197 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4986027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The viscosupplementation market is progressing through a period of technical innovation and shifting clinical practice patterns, requiring senior decision-makers to balance evolving operational, regulatory, and clinical priorities in a changing global environment. Market participants face new opportunities as well as complexities in product adoption and strategic execution.

Market Snapshot: Viscosupplementation Market Size and Trajectory

The viscosupplementation market is expected to grow from USD 3.20 billion in 2025 to USD 3.42 billion in 2026, advancing at a CAGR of 6.37% to reach USD 4.94 billion by 2032. This steady expansion is driven by the transition of viscosupplementation treatments from periodic relief of osteoarthritis symptoms to a more regularized element of comprehensive joint care plans. The adoption of improved, longer-lasting formulations and more accessible single-injection solutions encourages integration into diverse clinical settings. Meanwhile, adjustments in payer requirements and healthcare delivery models support broader therapy access across regions and care providers. These changes signal the market’s evolution toward more sustainable, patient-centric solutions and real-world efficacy measures, with strategic alignment around product innovation and clinical outcomes.

Scope & Segmentation of the Viscosupplementation Market

  • Product Types: Cross-linked hyaluronic acid products—available in multiple and single injection formats—and non cross-linked solutions, distinguishing high, medium, and low molecular weight variants. This variety ensures compatibility with varying patient profiles and clinical workflow requirements.
  • Clinical Applications: Targeted therapies for osteoarthritis affecting the ankle, hip, knee, and shoulder. Tailored product formulations are designed to achieve specific functional and anatomical outcomes for each joint area.
  • Distribution Channels: Hospital pharmacies, retail pharmacies, and online platforms—including mail order and prescription portals—define patient access pathways and therapy fulfillment efficiency, supporting a broader spectrum of care models.
  • End Users: Home care (self or assisted administration), hospitals, outpatient clinics, orthopedic practices, and rheumatology clinics, reflecting scalability and spectrum of clinical expertise across user environments.
  • Technologies: Engineered cross-linked hyaluronic acid matrices, next-generation single-injection options, integration of digital health tools, remote patient monitoring, and programs generating real-world evidence. These technology applications address both patient outcomes and operational continuity.
  • Regions Covered: Americas, Europe, Middle East & Africa, and Asia-Pacific. Each geographic area features distinct procurement approaches, readiness for technology adoption, and varying regulatory conditions, driving unique strategies for market entry and growth.

Key Takeaways for Senior Decision-Makers

  • Viscosupplementation is being embedded within broader, multimodal osteoarthritis care strategies, expanding beyond episodic symptom relief to long-term disease management integration.
  • Improvements in formulation now emphasize extended durability and reduced frequency of administration, aiming to increase patient satisfaction and enhance operational efficiency for providers.
  • Minimally invasive, single-injection treatments are enabling a shift in care delivery, allowing therapy to move from hospital settings to outpatient and at-home environments and supporting decentralized care models.
  • Adoption of digital follow-up and real-world evidence programs is accelerating, meeting growing demands from payers and institutions for demonstrable outcomes and longitudinal patient tracking.
  • Strategic coordination among manufacturers, distributors, and provider networks is playing a larger role in market expansion and operational scale, as collaboration becomes key to delivery efficiency and market presence.
  • Regional variability in regulatory approval and reimbursement structures requires flexible, localized market entry and deployment plans, reflecting diverse infrastructure and clinical capabilities across geographies.

Tariff Impact: Supply Chain and Procurement Considerations

Recent adjustments to tariff structures are leading to new cost dynamics and operational complexity, particularly for organizations sourcing critical inputs such as polymers and prefilled syringes from cross-border suppliers. Vertically integrated businesses and those with domestic manufacturing capabilities are less exposed, while companies relying on imported components must address procurement constraints by renegotiating contracts, securing inventory preemptively, and identifying alternative suppliers. These developments are resulting in shifting product availability trends and are prompting greater adaptability in procurement and delivery models throughout the viscosupplementation market.

Methodology & Data Sources

This report is grounded in a mixed-methods approach, drawing on focused interviews with clinicians, procurement leaders, and supply chain experts, along with in-depth secondary analysis of regulatory documents, clinical literature, and market policy guidelines. Segmentation and realistic scenario modeling were used to test practical use cases, supported by expert feedback.

Why This Report Matters

  • Presents actionable market segmentation tied to workflows, procurement, and reimbursement criteria, supporting precise, informed strategic decision-making for business leaders.
  • Clarifies current challenges in technologies and regulation, enabling organizations to evaluate investment potential and partnership strategies throughout the viscosupplementation market.
  • Details essential implications for adoption, supply resilience, and commercial responsiveness, supporting sustainable operational planning over the long term.

Conclusion

Effective alignment of technology, supply chain agility, and validated clinical results will be essential as the viscosupplementation market evolves. Organizations that keep pace with regulatory and stakeholder shifts can enhance competitive resilience and optimize clinical and commercial outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Viscosupplementation Market, by Product Type
8.1. Cross Linked Hyaluronic Acid
8.1.1. Multiple Injection
8.1.2. Single Injection
8.2. Non Cross Linked Hyaluronic Acid
8.2.1. High Molecular Weight
8.2.2. Low Molecular Weight
8.2.3. Medium Molecular Weight
9. Viscosupplementation Market, by Application Area
9.1. Ankle Osteoarthritis
9.2. Hip Osteoarthritis
9.3. Knee Osteoarthritis
9.4. Shoulder Osteoarthritis
10. Viscosupplementation Market, by Distribution Channel
10.1. Hospital Pharmacies
10.2. Online Pharmacies
10.2.1. Mail Order Services
10.2.2. Prescription Portals
10.3. Retail Pharmacies
11. Viscosupplementation Market, by End User
11.1. Home Care
11.1.1. Assisted Administration
11.1.2. Self Administration
11.2. Hospitals
11.3. Outpatient Clinics
11.3.1. Orthopedic Practices
11.3.2. Rheumatology Clinics
12. Viscosupplementation Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Viscosupplementation Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Viscosupplementation Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Viscosupplementation Market
16. China Viscosupplementation Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Anika Therapeutics, Inc.
17.6. Bioventus Inc.
17.7. Ferring International Center SA
17.8. LG Chem Ltd.
17.9. Lifecore Biomedical, LLC
17.10. Sanofi SA
17.11. Seikagaku Corporation
17.12. Smith & Nephew plc
17.13. Teva Pharmaceutical Industries Ltd.
17.14. TRB Chemedica AG
17.15. Zimmer Biomet Holdings, Inc.
List of Figures
FIGURE 1. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL VISCOSUPPLEMENTATION MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL VISCOSUPPLEMENTATION MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA VISCOSUPPLEMENTATION MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY MULTIPLE INJECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY MULTIPLE INJECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY MULTIPLE INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HIGH MOLECULAR WEIGHT, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HIGH MOLECULAR WEIGHT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HIGH MOLECULAR WEIGHT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY LOW MOLECULAR WEIGHT, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY LOW MOLECULAR WEIGHT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY LOW MOLECULAR WEIGHT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY MEDIUM MOLECULAR WEIGHT, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY MEDIUM MOLECULAR WEIGHT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY MEDIUM MOLECULAR WEIGHT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ANKLE OSTEOARTHRITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ANKLE OSTEOARTHRITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ANKLE OSTEOARTHRITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HIP OSTEOARTHRITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HIP OSTEOARTHRITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HIP OSTEOARTHRITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY KNEE OSTEOARTHRITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY KNEE OSTEOARTHRITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY KNEE OSTEOARTHRITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SHOULDER OSTEOARTHRITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SHOULDER OSTEOARTHRITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SHOULDER OSTEOARTHRITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY MAIL ORDER SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY MAIL ORDER SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY MAIL ORDER SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRESCRIPTION PORTALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRESCRIPTION PORTALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRESCRIPTION PORTALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ASSISTED ADMINISTRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ASSISTED ADMINISTRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ASSISTED ADMINISTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SELF ADMINISTRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SELF ADMINISTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ORTHOPEDIC PRACTICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ORTHOPEDIC PRACTICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ORTHOPEDIC PRACTICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY RHEUMATOLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY RHEUMATOLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY RHEUMATOLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 82. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 83. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 84. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 85. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 86. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 87. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 88. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 89. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. NORTH AMERICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 95. NORTH AMERICA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. LATIN AMERICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 103. LATIN AMERICA VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 109. LATIN AMERICA VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2032 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2032 (USD MILLION)
TABLE 121. EUROPE VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. EUROPE VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 123. EUROPE VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 124. EUROPE VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 125. EUROPE VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 126. EUROPE VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 127. EUROPE VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 128. EUROPE VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 129. EUROPE VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 130. EUROPE VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2032 (USD MILLION)
TABLE 131. MIDDLE EAST VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. MIDDLE EAST VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 133. MIDDLE EAST VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 134. MIDDLE EAST VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 135. MIDDLE EAST VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 136. MIDDLE EAST VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 137. MIDDLE EAST VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 138. MIDDLE EAST VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. MIDDLE EAST VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 140. MIDDLE EAST VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2032 (USD MILLION)
TABLE 141. AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 143. AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 144. AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 145. AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 146. AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 147. AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 148. AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 149. AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 150. AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 162. ASEAN VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. ASEAN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 164. ASEAN VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 165. ASEAN VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 166. ASEAN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 167. ASEAN VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 168. ASEAN VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 169. ASEAN VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. ASEAN VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 171. ASEAN VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2032 (USD MILLION)
TABLE 172. GCC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 173. GCC VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 174. GCC VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 175. GCC VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 176. GCC VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 177. GCC VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 178. GCC VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 179. GCC VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 180. GCC VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 181. GCC VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 189. EUROPEAN UNION VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 190. EUROPEAN UNION VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2032 (USD MILLION)
TABLE 192. BRICS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. BRICS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 194. BRICS VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 195. BRICS VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 196. BRICS VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 197. BRICS VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 198. BRICS VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 199. BRICS VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 200. BRICS VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 201. BRICS VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2032 (USD MILLION)
TABLE 202. G7 VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 203. G7 VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 204. G7 VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 205. G7 VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 206. G7 VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 207. G7 VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 208. G7 VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 209. G7 VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 210. G7 VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 211. G7 VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2032 (USD MILLION)
TABLE 212. NATO VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 213. NATO VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 214. NATO VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 215. NATO VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 216. NATO VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 217. NATO VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 218. NATO VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 219. NATO VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 220. NATO VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 221. NATO VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2032 (USD MILLION)
TABLE 222. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 223. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 224. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 225. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 226. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 227. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 228. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 229. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 230. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 231. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 232. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2032 (USD MILLION)
TABLE 233. CHINA VISCOSUPPLEMENTATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 234. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 235. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 236. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 237. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 238. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 239. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 240. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 241. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 242. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Viscosupplementation market report include:
  • Anika Therapeutics, Inc.
  • Bioventus Inc.
  • Ferring International Center SA
  • LG Chem Ltd.
  • Lifecore Biomedical, LLC
  • Sanofi SA
  • Seikagaku Corporation
  • Smith & Nephew plc
  • Teva Pharmaceutical Industries Ltd.
  • TRB Chemedica AG
  • Zimmer Biomet Holdings, Inc.

Table Information

Report AttributeDetails
No. of Pages197
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3.42 Billion
Forecasted Market Value ( USD ) by 2032 $ 4.94 Billion
Compound Annual Growth Rate6.3%
Regions CoveredGlobal
No. of Companies Mentioned12

Related Topics

Related Reports

Viscosupplementation Treatment for Arthritis Global Market Report 2025 - Product Image

Viscosupplementation Treatment for Arthritis Global Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Viscosupplementation Injection Market - Global Forecast 2025-2030 - Product Image

Viscosupplementation Injection Market - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Hyaluronic Acid Viscosupplementation Market Size, Share, and Trends Analysis | Global | 2025-2031 | MedCore | Includes: Single Injection Market, Two Injection Market, and 2 more - Product Image

Hyaluronic Acid Viscosupplementation Market Size, Share, and Trends Analysis | Global | 2025-2031 | MedCore | Includes: Single Injection Market, Two Injection Market, and 2 more

  • Report
  • 60 Pages
  • Global
From
Viscosupplementation Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Viscosupplementation Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Viscosupplementation Market Report 2025 - Product Image

Viscosupplementation Market Report 2025

  • Report
  • 250 Pages
  • Global
From

About the Viscosupplementation Market

Viscosupplementation is a type of orthopedic device used to treat joint pain caused by osteoarthritis. It involves injecting a gel-like substance, known as a viscosupplement, into the affected joint. The viscosupplement is designed to lubricate the joint and reduce pain and inflammation. It is typically used when other treatments, such as physical therapy and medications, have not been successful. Viscosupplementation is a relatively new technology and is becoming increasingly popular as an alternative to more invasive treatments, such as joint replacement surgery. It is generally considered to be safe and effective, with few side effects. Some of the companies in the viscosupplementation market include Zimmer Biomet, Smith & Nephew, Stryker, and DePuy Synthes. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.